Why the study?
Does low-dose aspirin (160 mg per day) prevent thrombosis in patients on chronic hemodialysis?
Population
44 patients on chronic hemodialysis
Comparison
Aspirin 160 mg per day vs Placebo
Design
RCT, randomized, double-blind
Follow-up
mean of nearly five months
Authors
Loading...
Supports aspirin for thrombosis prevention in hemodialysis; confirms benefit in this high-risk population.
Does low-dose aspirin (160 mg per day) prevent thrombosis in patients on chronic hemodialysis?
Low-dose aspirin (160 mg per day) significantly reduces the incidence of thrombosis in patients on chronic hemodialysis.
Harter et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: